MARLIN THERAPEUTICS LTD
NOTTINGHAM

Hellopages » Nottinghamshire » Nottingham » NG7 2RF

Company number 10726172
Status Active
Incorporation Date 13 April 2017
Company Type Private Limited Company
Address UNIT 6 EDISON VILLAGE, NOTTINGHAM SCIENCE PARK, NOTTINGHAM, UNITED KINGDOM, NG7 2RF
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration nine events have happened. The last three records are Appointment of Ms Stephanie Anne Hamblin as a director on 24 May 2017; Statement of capital following an allotment of shares on 19 May 2017 GBP 10.53 ; Statement of capital following an allotment of shares on 2 May 2017 GBP 1 . The most likely internet sites of MARLIN THERAPEUTICS LTD are www.marlintherapeutics.co.uk, and www.marlin-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is eight years and ten months. Marlin Therapeutics Ltd is a Private Limited Company. The company registration number is 10726172. Marlin Therapeutics Ltd has been working since 13 April 2017. The present status of the company is Active. The registered address of Marlin Therapeutics Ltd is Unit 6 Edison Village Nottingham Science Park Nottingham United Kingdom Ng7 2rf. . BATES, Timothy Edward, Dr is a Director of the company. DAINTY, Roger James is a Director of the company. HAMBLIN, Stephanie Anne is a Director of the company. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
BATES, Timothy Edward, Dr
Appointed Date: 13 April 2017
65 years old

Director
DAINTY, Roger James
Appointed Date: 10 May 2017
79 years old

Director
HAMBLIN, Stephanie Anne
Appointed Date: 24 May 2017
58 years old

Persons With Significant Control

Dr Timothy Edward Bates
Notified on: 13 April 2017
65 years old
Nature of control: Ownership of shares – 75% or more

MARLIN THERAPEUTICS LTD Events

24 May 2017
Appointment of Ms Stephanie Anne Hamblin as a director on 24 May 2017
24 May 2017
Statement of capital following an allotment of shares on 19 May 2017
  • GBP 10.53

18 May 2017
Statement of capital following an allotment of shares on 2 May 2017
  • GBP 1

18 May 2017
Statement of capital following an allotment of shares on 2 May 2017
  • GBP 8

16 May 2017
Sub-division of shares on 2 May 2017
12 May 2017
Resolutions
  • RES13 ‐ 02/05/2017

12 May 2017
Appointment of Roger James Dainty as a director on 10 May 2017
09 May 2017
Current accounting period shortened from 30 April 2018 to 31 March 2018
13 Apr 2017
Incorporation
Statement of capital on 2017-04-13
  • GBP 1
  • MODEL ARTICLES ‐ Model articles adopted